|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 9/0014 | (2013.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61K 9/14 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/44 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61P 23/02 | (2006.01) | ||
| A61K 9/1075 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/167 | (2013.01) | ||
| A61K 31/616 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/616 | (2013.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 23/02 | (2018.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 2938324 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13869707.3 |
| Date of filing the European patent application | 2013-12-27 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/077985 |
| Date | 2013-12-27 |
| (87) | Number | WO 2014/106048 |
| Date | 2014-07-03 |
| (30) | Number | Date | Country code |
| 201261748036 P | 2012-12-31 | US | |
| 201361758726 P | 2013-01-30 | US |
| (72) |
JORDAN, Frederick, L. , US
JORDAN, Chris , US
|
| (73) |
JRX Biotechnology, Inc. ,
8502 E Chapman Ave., No. 648, Orange, CA 92869,
US
|
| (54) | LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS |
| LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS |